AGP Picks
View all

Press Releases

Stay up to date with press releases covering announcements, company news, product launches, and business updates.

Publish your press release
fallback image
Sep. 16, 2025

Opening Latin America’s Door to Health Tourism: Medical Tourism Packages Transforms Travel, Wellness, & Self-Improvement

EIN Presswire

fallback image
Feb. 12, 2026

Juan Carlos Torres del Río shares a safety checklist for choosing a surgeon and clinic with confidence

EIN Presswire

fallback image
Feb. 10, 2026

Future-Proofing Healthcare Delivery: SuperStaff Expands HIPAA-Certified Capabilities for Global Providers

EIN Presswire

fallback image
Feb. 5, 2026

Chiesi Global Rare Diseases Reinforces Long-Term Commitment to the Rare Disease Community with Multiple Abstract Presentations at the 22nd Annual WORLDSymposium™

GlobeNewswire, Inc.

fallback image
Feb. 3, 2026

Lloyd & Mousilli Expands U.S. Presence with New Location in Coral Gables

EIN Presswire

fallback image
Feb. 5, 2026

Chiesi Global Rare Diseases Reinforces Long-Term Commitment to the Rare Disease Community with Multiple Abstract Presentations at the 22nd Annual WORLDSymposium™

GlobeNewswire, Inc.

fallback image
Nov. 14, 2025

Clinical Laboratory Instruments Market to Reach US$ 91.61 Billion by 2033 at 7.4% CAGR | DataM Intelligence

EIN Presswire

fallback image
Feb. 10, 2026

Historic Floods in Northern Colombia Trigger Humanitarian Crisis

MENAFN

fallback image
Feb. 10, 2026

Over Dozen Dead as Record Floods Batter Northern Colombia

MENAFN

fallback image
Jul. 15, 2026

Plasmid Purification Market Worth USD 2.47 Billion in 2026, Projected to Hit USD 4.82Billion by 2033 | CAGR of 11.8%

EIN Presswire

fallback image
Jan. 30, 2026

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) in the EU

GlobeNewswire, Inc.

fallback image
Jan. 30, 2026

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of 2mg/kg Body Weight Every-Four-Weeks for Elfabrio® (pegunigalsidase alfa) ▼ in the EU

GlobeNewswire, Inc.

fallback image
Jul. 17, 2026

Committee Cliff Notes: Weekly Recap -- Week of July 13, 2026

Majority Leader Louisiana

fallback image
Jan. 20, 2026

Peer-Reviewed Clinical Study Shows Ruby-O® Balance Achieves Triglyceride Response at Lower Omega-3 Dose

EIN Presswire

fallback image
Feb. 1, 2026

UN Says Humanitarian Situation in Colombia Deteriorates

MENAFN

fallback image
Jul. 9, 2026

Cattle Vaccine Market to Hit USD 6.17 Billion by 2033, says Coherent Market Insights

EIN Presswire

fallback image
Jan. 29, 2026

isoSolutions® to Exhibit Comprehensive Theranostics Solutions at WFNMB 2026 in Cartagena, Colombia

EIN Presswire

fallback image
Jan. 21, 2026

AI in Clinical Trials Poised for Rapid Growth with a 22.6% CAGR Forecast

GlobeNewswire, Inc.

fallback image
Jan. 22, 2026

Ecuador Security Tax on Colombian Imports to Take Effect Next Month

MENAFN

fallback image
Jan. 18, 2026

Four people die from gas inhalation at Colombian coal mine

MENAFN

Sign up for:

Health News Hub Colombia

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by: